Articles by Susan Haigney - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Susan Haigney

Susan Haigney

Managing Editor, Pharmaceutical Technology

Articles
Moving Toward a Safer Supply Chain
August 4, 2014

FDA's Secure Supply Chain Pilot Program, RX-360, and other industry efforts advance actions to secure the drug supply chain.

Securing the Supply Chain
July 2, 2014

Regulators and industry leaders take on the task of securing the drug supply chain.

Challenges in Managing the Cold Chain
December 11, 2013

Industry experts discuss challenges in managing the cold chain.

Implementing QbD in Sterile Manufacturing
December 2, 2013

Industry experts discuss the application, challenges, and benefits of a quality-by-design approach to sterile manufacturing.

FDA Creates Partnership to Battle Anti-Malaria Counterfeit Drugs
April 24, 2013

FDA will use a new anticounterfeiting tool to detect fake medicines.

Compounding Pharmacies Recall Products
April 16, 2013

FDA inspections of compounding pharmacies manufacturing sterile-drug products lead to voluntary recalls.

FDA Commissioner Claims Resistance to Compounding Pharmacy Inspections
April 12, 2013

FDA inspections of compounding pharmacies manufacturing sterile products reveal non-sterile conditions.

FDA Requests Almost $5 Billion for 2014 Budget
April 12, 2013

FDA's Fiscal Year 2014 budget request includes more than $10 million above the 2012 budget for inspections of products manufactured in China.

FDA Releases SUPAC Guidance
April 2, 2013

Draft guidance combines and supersedes previous guidance documents.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here